BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 25253076)

  • 1. Arrhythmogenic right ventricular cardiomyopathy mutations alter shear response without changes in cell-cell adhesion.
    Hariharan V; Asimaki A; Michaelson JE; Plovie E; MacRae CA; Saffitz JE; Huang H
    Cardiovasc Res; 2014 Nov; 104(2):280-9. PubMed ID: 25253076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Remodeling of the cardiac sodium channel, connexin43, and plakoglobin at the intercalated disk in patients with arrhythmogenic cardiomyopathy.
    Noorman M; Hakim S; Kessler E; Groeneweg JA; Cox MG; Asimaki A; van Rijen HV; van Stuijvenberg L; Chkourko H; van der Heyden MA; Vos MA; de Jonge N; van der Smagt JJ; Dooijes D; Vink A; de Weger RA; Varro A; de Bakker JM; Saffitz JE; Hund TJ; Mohler PJ; Delmar M; Hauer RN; van Veen TA
    Heart Rhythm; 2013 Mar; 10(3):412-9. PubMed ID: 23178689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modeling of arrhythmogenic right ventricular cardiomyopathy with human induced pluripotent stem cells.
    Caspi O; Huber I; Gepstein A; Arbel G; Maizels L; Boulos M; Gepstein L
    Circ Cardiovasc Genet; 2013 Dec; 6(6):557-68. PubMed ID: 24200905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of patient-specific induced pluripotent stem cell-derived cardiomyocytes as a cellular model of arrhythmogenic right ventricular cardiomyopathy.
    Ma D; Wei H; Lu J; Ho S; Zhang G; Sun X; Oh Y; Tan SH; Ng ML; Shim W; Wong P; Liew R
    Eur Heart J; 2013 Apr; 34(15):1122-33. PubMed ID: 22798562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered desmosomal proteins in granulomatous myocarditis and potential pathogenic links to arrhythmogenic right ventricular cardiomyopathy.
    Asimaki A; Tandri H; Duffy ER; Winterfield JR; Mackey-Bojack S; Picken MM; Cooper LT; Wilber DJ; Marcus FI; Basso C; Thiene G; Tsatsopoulou A; Protonotarios N; Stevenson WG; McKenna WJ; Gautam S; Remick DG; Calkins H; Saffitz JE
    Circ Arrhythm Electrophysiol; 2011 Oct; 4(5):743-52. PubMed ID: 21859801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac tissue-restricted deletion of plakoglobin results in progressive cardiomyopathy and activation of {beta}-catenin signaling.
    Li J; Swope D; Raess N; Cheng L; Muller EJ; Radice GL
    Mol Cell Biol; 2011 Mar; 31(6):1134-44. PubMed ID: 21245375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening of pathogenic genes in Chinese patients with arrhythmogenic right ventricular cardiomyopathy.
    Bao JR; Wang JZ; Yao Y; Wang YL; Fan XH; Sun K; Zhang S; Hui RT; Song L
    Chin Med J (Engl); 2013 Nov; 126(22):4238-41. PubMed ID: 24238504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterizing the Molecular Pathology of Arrhythmogenic Cardiomyopathy in Patient Buccal Mucosa Cells.
    Asimaki A; Protonotarios A; James CA; Chelko SP; Tichnell C; Murray B; Tsatsopoulou A; Anastasakis A; te Riele A; Kléber AG; Judge DP; Calkins H; Saffitz JE
    Circ Arrhythm Electrophysiol; 2016 Feb; 9(2):e003688. PubMed ID: 26850880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel dominant mutation in plakoglobin causes arrhythmogenic right ventricular cardiomyopathy.
    Asimaki A; Syrris P; Wichter T; Matthias P; Saffitz JE; McKenna WJ
    Am J Hum Genet; 2007 Nov; 81(5):964-73. PubMed ID: 17924338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abnormal connexin43 in arrhythmogenic right ventricular cardiomyopathy caused by plakophilin-2 mutations.
    Fidler LM; Wilson GJ; Liu F; Cui X; Scherer SW; Taylor GP; Hamilton RM
    J Cell Mol Med; 2009 Oct; 13(10):4219-28. PubMed ID: 18662195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of canonical Wnt/beta-catenin signaling by nuclear plakoglobin recapitulates phenotype of arrhythmogenic right ventricular cardiomyopathy.
    Garcia-Gras E; Lombardi R; Giocondo MJ; Willerson JT; Schneider MD; Khoury DS; Marian AJ
    J Clin Invest; 2006 Jul; 116(7):2012-21. PubMed ID: 16823493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel missense mutations in exon 15 of desmoglein-2: role of the intracellular cadherin segment in arrhythmogenic right ventricular cardiomyopathy?
    Gehmlich K; Asimaki A; Cahill TJ; Ehler E; Syrris P; Zachara E; Re F; Avella A; Monserrat L; Saffitz JE; McKenna WJ
    Heart Rhythm; 2010 Oct; 7(10):1446-53. PubMed ID: 20708101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the molecular phenotype of two arrhythmogenic right ventricular cardiomyopathy (ARVC)-related plakophilin-2 (PKP2) mutations.
    Joshi-Mukherjee R; Coombs W; Musa H; Oxford E; Taffet S; Delmar M
    Heart Rhythm; 2008 Dec; 5(12):1715-23. PubMed ID: 19084810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arrhythmogenic right ventricular dysplasia, a cell adhesion cardiomyopathy: insights into disease pathogenesis from preliminary genotype--phenotype assessment.
    Tsatsopoulou AA; Protonotarios NI; McKenna WJ
    Heart; 2006 Dec; 92(12):1720-3. PubMed ID: 16698823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Age- and training-dependent development of arrhythmogenic right ventricular cardiomyopathy in heterozygous plakoglobin-deficient mice.
    Kirchhof P; Fabritz L; Zwiener M; Witt H; Schäfers M; Zellerhoff S; Paul M; Athai T; Hiller KH; Baba HA; Breithardt G; Ruiz P; Wichter T; Levkau B
    Circulation; 2006 Oct; 114(17):1799-806. PubMed ID: 17030684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new diagnostic test for arrhythmogenic right ventricular cardiomyopathy.
    Asimaki A; Tandri H; Huang H; Halushka MK; Gautam S; Basso C; Thiene G; Tsatsopoulou A; Protonotarios N; McKenna WJ; Calkins H; Saffitz JE
    N Engl J Med; 2009 Mar; 360(11):1075-84. PubMed ID: 19279339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical expression of plakophilin-2 mutations in familial arrhythmogenic right ventricular cardiomyopathy.
    Syrris P; Ward D; Asimaki A; Sen-Chowdhry S; Ebrahim HY; Evans A; Hitomi N; Norman M; Pantazis A; Shaw AL; Elliott PM; McKenna WJ
    Circulation; 2006 Jan; 113(3):356-64. PubMed ID: 16415378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arrhythmogenic right ventricular cardiomyopathy caused by deletions in plakophilin-2 and plakoglobin (Naxos disease) in families from Greece and Cyprus: genotype-phenotype relations, diagnostic features and prognosis.
    Antoniades L; Tsatsopoulou A; Anastasakis A; Syrris P; Asimaki A; Panagiotakos D; Zambartas C; Stefanadis C; McKenna WJ; Protonotarios N
    Eur Heart J; 2006 Sep; 27(18):2208-16. PubMed ID: 16893920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Arrhythmogenic right ventricular cardiomyopathy: moving toward mechanism.
    MacRae CA; Birchmeier W; Thierfelder L
    J Clin Invest; 2006 Jul; 116(7):1825-8. PubMed ID: 16823481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plakophilin-2 mutations as a cause of arrhythmogenic right ventricular cardiomyopathy: progress toward linking structural with functional changes.
    Ram R; Van Wagoner DR
    Heart Rhythm; 2008 Dec; 5(12):1724-5. PubMed ID: 19084811
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.